CSPC 2019 has ended
avatar for Mark Poznansky

Mark Poznansky

Spindle Strategy Corp.
Senior Advisor

Mark is a Senior Advisor with Spindle and the former CEO of Ontario Genomics – a provincial genomics-focused enabler – which he led from 2010 to 2017. During his tenure, he established the organization as a forward-thinking advocate for genomics-enabled technological and industrial transformation. He instituted a pioneering demand-pull model to facilitate the uptake of home-grown genomics innovations into local and global agriculture, water, mining, forestry and energy sectors and developed mechanisms for securing millions in federal and industry funds in support of Ontario’s genomics research. Dr. Poznansky served as President and Scientific Director of Robarts Research Institute (London, Ontario) from 1993 to 2007, over which time the institute increased its staff from 100 to over 600, grew its annual research funding from $10 million to over $40 million, and developed a reputation for business development by spinning out seven different companies, including Viron Therapeutics, where Dr. Poznansky served as President and CEO. He has also served on the Merck USA Scientific Advisory Leadership Team, acted as Associate Dean of Medicine for Research at the University of Alberta and held faculty positions at the University of Western Ontario, University of Alberta and Harvard University. Dr. Poznansky was made a member of the Order of Ontario in 2004 and the Order of Canada in 2005.